Eocene System
510(k) K090712
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK090712 | Date2 Oct 2009 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- NBW
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1345
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
The Eocene System is a device in the Clinical Chemistry category, as indicated by the advisory committee classification. It received FDA 510(k) clearance as substantially equivalent to a legally marketed device.
The system was cleared through a special 510(k) process and is manufactured by Infopia Co, Ltd. It is identified by the product code NBW and k-number K090712, with authorization granted on October 2, 2009.
Other devices from Infopia Co, Ltd.
Questions
AI-generated answers, 21 Sep 2026
What is the Eocene System used for?
The Eocene System is classified under the Clinical Chemistry category by the FDA advisory committee, indicating its use in clinical laboratory settings for analyzing chemical components in bodily fluids to aid in diagnosis and monitoring of medical conditions.
How is the Eocene System supplied and is it sterile or single-use?
The device data does not specify supply format, sterility, or single-use/reuse status for the Eocene System; such details would typically be found in the device’s labeling or instructions for use, which are not included in the provided authorization records.
What regulatory pathway was used for the Eocene System and what does its clearance mean?
The Eocene System received FDA 510(k) clearance through a special 510(k) process, meaning it was determined to be substantially equivalent to a legally marketed predicate device, allowing it to be legally marketed in the U.S. for its intended use.